Riyadh – Mubasher: Al Modawat Specialized Medical Company announced that its board of directors approved the formation of the Nomination and Remuneration Committee on 11 July 2026.

The committee consists of three members appointed to oversee governance and compensation functions for the current board cycle, according to a bourse disclosure.

The newly formed committee is chaired by Nawaf Hamza Abdullah Bawazir, an independent board member. The remaining two seats are held by Ahmed Ali Abdel Fattah Hassan and Ahmed Salah Ahmed Helal, both of whom serve as members from outside the board of directors.

The term for the committee members commenced on 11 July. According to the regulatory filing, their membership is scheduled to conclude upon the expiration of the current board of directors' term on 8 June 2027.

On 17 June, the company’s shareholders authorized the Board of Directors to distribute interim dividends for the 2026 fiscal year and passed significant governance frameworks and related-party transactions.